Paul Silva - Vertex Pharmaceuticals Insider

Vertex Pharmaceuticals Incorporated -- USA Stock  

USD 154.6  0.26  0.17%

Senior Vice President Corporate Controller

Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50  President Since 2011      
Silva holds a B.S. in accounting from Assumption College.

Paul Silva Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 7.67 % which means that it generated profit of $7.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 17.72 % meaning that it created $17.72 on every $100 dollars invested by stockholders.
The company currently holds 568.54 M in liabilities with Debt to Equity (D/E) ratio of 30.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.42 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives


Timothy ErnstBio Rad Laboratories Inc
Kevin KnightlyQuintiles IMS Holdings Inc
Deepak NathAbbott Laboratories
Matthew MalettaEndo International plc
Philippe SchaisonAllergan plc
Richard StaubQuintiles IMS Holdings Inc
Andrew LaneAbbott Laboratories
Robert StewartAllergan plc
Joseph ManningAbbott Laboratories
Jared WatkinAbbott Laboratories
Michael WarmuthAbbott Laboratories
Blaise ColemanEndo International plc
James ErlingerQuintiles IMS Holdings Inc
JeanYves PaveeAbbott Laboratories
Michael McDonnellQuintiles IMS Holdings Inc
Scott WhiteAbbott Laboratories
Eric FainAbbott Laboratories
Paul NavarreAllergan plc
Roger BirdAbbott Laboratories
Antonio PeraEndo International plc
Ronald HuttonBio Rad Laboratories Inc

Entity Summary

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing medicines for serious diseases. Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 1,950 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Fundamentals Matrix Now

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
Hide  View All  Next  Launch Fundamentals Matrix
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vertex Pharmaceuticals Incorporated to your portfolio

Top Management

Vertex Pharmaceuticals Leadership Team
Paul Silva, President
William Young, Director, MBA
David Altshuler, Director
Jeffrey Chodakewitz, President
Elaine Ullian, Director
Michael Parini, President
Alan Garber, Director, Ph.D
Amit Sachdev, President
Joshua Boger, Chairman
David Greenway, Director
Bruce Sachs, Director, MBA
Margaret McGlynn, Director, MBA
Michael Partridge, President
Yuchun Lee, Director, MBA
Sangeeta Bhatia, Director, Ph.D
Stuart Arbuckle, EVP
Thomas Graney, President, MBA
Terrence Kearney, Director, MBA
Ian Smith, President
Jeffrey Leiden, Chairman, Ph.D

Stock Performance

Vertex Pharmaceuticals Performance Indicators